1. Home
  2. EEX vs SYRE Comparison

EEX vs SYRE Comparison

Compare EEX & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EEX
  • SYRE
  • Stock Information
  • Founded
  • EEX 2013
  • SYRE 2013
  • Country
  • EEX United States
  • SYRE United States
  • Employees
  • EEX N/A
  • SYRE N/A
  • Industry
  • EEX Advertising
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • EEX Consumer Discretionary
  • SYRE Health Care
  • Exchange
  • EEX Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • EEX 1.0B
  • SYRE 1.1B
  • IPO Year
  • EEX 2017
  • SYRE 2016
  • Fundamental
  • Price
  • EEX $4.96
  • SYRE $15.86
  • Analyst Decision
  • EEX Strong Buy
  • SYRE Buy
  • Analyst Count
  • EEX 2
  • SYRE 5
  • Target Price
  • EEX $7.95
  • SYRE $55.00
  • AVG Volume (30 Days)
  • EEX 34.7K
  • SYRE 414.7K
  • Earning Date
  • EEX 10-29-2025
  • SYRE 11-06-2025
  • Dividend Yield
  • EEX 1.22%
  • SYRE N/A
  • EPS Growth
  • EEX N/A
  • SYRE N/A
  • EPS
  • EEX 0.04
  • SYRE N/A
  • Revenue
  • EEX $432,600,000.00
  • SYRE N/A
  • Revenue This Year
  • EEX $15.99
  • SYRE N/A
  • Revenue Next Year
  • EEX $7.56
  • SYRE N/A
  • P/E Ratio
  • EEX $134.21
  • SYRE N/A
  • Revenue Growth
  • EEX 9.96
  • SYRE N/A
  • 52 Week Low
  • EEX $3.22
  • SYRE $10.91
  • 52 Week High
  • EEX $6.45
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • EEX 50.11
  • SYRE 42.99
  • Support Level
  • EEX $4.80
  • SYRE $15.80
  • Resistance Level
  • EEX $5.45
  • SYRE $17.58
  • Average True Range (ATR)
  • EEX 0.22
  • SYRE 0.74
  • MACD
  • EEX -0.02
  • SYRE -0.11
  • Stochastic Oscillator
  • EEX 37.69
  • SYRE 9.78

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: